Cornerstone Robotics Sentire® System Certified in EU, Singapore
Analysis based on 9 articles · First reported May 25, 2026 · Last updated May 25, 2026
The certifications for the Sentire Surgical System by Cornerstone Robotics open up significant market opportunities in Europe and Asia-Pacific, potentially increasing the company's revenue and market share in the surgical robotics industry. This positive development is likely to boost investor confidence in Cornerstone Robotics, following its successful US$200 million financing round in November 2025.
Cornerstone Robotics, a China — Hong Kong-based surgical robotics innovator, announced that its Sentire Surgical System has received European Union CE mark certification under the Medical Device Regulation (MDR) and Singapore Singapore — Health Sciences Authority (HSA) certification. These approvals grant the Sentire Surgical System access to both European and Asia-Pacific markets for minimally invasive surgical procedures in General Surgery, Gynecology, Thoracic, and Urology. The company has been conducting clinical investigations in the United Kingdom since 2025 with Portsmouth Hospitals University NHS Trust and has established a UK subsidiary for localized services. In Singapore, Cornerstone Robotics signed an MOU with NHG Health and Lee Kong Chian School of Medicine and completed the first installation of the Sentire Surgical System at Woodlands Hospital. This regulatory success follows a US$200 million financing round in November 2025, positioning Cornerstone Robotics for accelerated global adoption of its surgical robotic solutions.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard